Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.91 Billion BRL | 4.88% |
| 2022 | 7.54 Billion BRL | 27.1% |
| 2021 | 5.93 Billion BRL | 45.21% |
| 2020 | 4.08 Billion BRL | 24.1% |
| 2019 | 3.29 Billion BRL | -11.53% |
| 2018 | 3.72 Billion BRL | 2.36% |
| 2017 | 3.63 Billion BRL | 10.63% |
| 2016 | 3.28 Billion BRL | 11.23% |
| 2015 | 2.95 Billion BRL | -36.83% |
| 2014 | 4.68 Billion BRL | 9.9% |
| 2013 | 4.25 Billion BRL | 9.94% |
| 2012 | 3.87 Billion BRL | 16.51% |
| 2011 | 3.32 Billion BRL | 5.22% |
| 2010 | 3.15 Billion BRL | 56.01% |
| 2009 | 2.02 Billion BRL | 51.93% |
| 2008 | 1.33 Billion BRL | 25.58% |
| 2007 | 1.06 Billion BRL | 179.15% |
| 2006 | 380.26 Million BRL | 9.68% |
| 2005 | 346.7 Million BRL | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.82 Billion BRL | -1.1% |
| 2024 Q2 | 2.18 Billion BRL | 19.83% |
| 2023 Q3 | 2.13 Billion BRL | -4.15% |
| 2023 Q1 | 1.69 Billion BRL | -19.95% |
| 2023 FY | 7.91 Billion BRL | 4.88% |
| 2023 Q2 | 2.23 Billion BRL | 31.38% |
| 2023 Q4 | 1.84 Billion BRL | -13.63% |
| 2022 Q1 | 1.49 Billion BRL | -8.17% |
| 2022 Q2 | 1.89 Billion BRL | 26.92% |
| 2022 Q3 | 2.03 Billion BRL | 7.39% |
| 2022 Q4 | 2.12 Billion BRL | 4.21% |
| 2022 FY | 7.54 Billion BRL | 27.1% |
| 2021 Q3 | 1.63 Billion BRL | 8.31% |
| 2021 FY | 5.93 Billion BRL | 45.21% |
| 2021 Q1 | 1.17 Billion BRL | 3.17% |
| 2021 Q2 | 1.5 Billion BRL | 28.74% |
| 2021 Q4 | 1.62 Billion BRL | -0.38% |
| 2020 FY | 4.08 Billion BRL | 24.1% |
| 2020 Q2 | 1.05 Billion BRL | 28.89% |
| 2020 Q1 | 815.03 Million BRL | -12.23% |
| 2020 Q4 | 1.13 Billion BRL | 4.26% |
| 2020 Q3 | 1.08 Billion BRL | 3.62% |
| 2019 Q4 | 928.59 Million BRL | -7.98% |
| 2019 Q1 | 383.57 Million BRL | -58.65% |
| 2019 Q3 | 1 Billion BRL | 3.66% |
| 2019 Q2 | 973.45 Million BRL | 153.78% |
| 2019 FY | 3.29 Billion BRL | -11.53% |
| 2018 Q3 | 948.84 Million BRL | 3.13% |
| 2018 Q1 | 927.85 Million BRL | 2.68% |
| 2018 FY | 3.72 Billion BRL | 2.36% |
| 2018 Q4 | 927.54 Million BRL | -2.24% |
| 2018 Q2 | 920.05 Million BRL | -0.84% |
| 2017 Q3 | 954.62 Million BRL | 12.01% |
| 2017 Q2 | 852.27 Million BRL | -8.15% |
| 2017 Q1 | 927.94 Million BRL | 10.03% |
| 2017 FY | 3.63 Billion BRL | 10.63% |
| 2017 Q4 | 903.62 Million BRL | -5.34% |
| 2016 Q3 | 811.04 Million BRL | 0.49% |
| 2016 FY | 3.28 Billion BRL | 11.23% |
| 2016 Q4 | 843.33 Million BRL | 3.98% |
| 2016 Q2 | 807.06 Million BRL | -2.45% |
| 2016 Q1 | 827.29 Million BRL | 202.65% |
| 2015 Q2 | 1.25 Billion BRL | 5.71% |
| 2015 Q3 | 1.31 Billion BRL | 5.08% |
| 2015 Q4 | -805.95 Million BRL | -161.09% |
| 2015 FY | 2.95 Billion BRL | -36.83% |
| 2015 Q1 | 1.18 Billion BRL | -8.71% |
| 2014 Q1 | 1.05 Billion BRL | -5.36% |
| 2014 Q4 | 1.3 Billion BRL | 9.55% |
| 2014 Q3 | 1.18 Billion BRL | 4.85% |
| 2014 FY | 4.68 Billion BRL | 9.9% |
| 2014 Q2 | 1.13 Billion BRL | 6.98% |
| 2013 Q3 | 1.11 Billion BRL | 4.04% |
| 2013 Q2 | 1.06 Billion BRL | 11.55% |
| 2013 Q1 | 958.43 Million BRL | -6.65% |
| 2013 FY | 4.25 Billion BRL | 9.94% |
| 2013 Q4 | 1.11 Billion BRL | 0.58% |
| 2012 Q4 | 1.02 Billion BRL | 3.41% |
| 2012 Q1 | 897.11 Million BRL | 41.33% |
| 2012 Q2 | 956.96 Million BRL | 6.67% |
| 2012 Q3 | 992.87 Million BRL | 3.75% |
| 2012 FY | 3.87 Billion BRL | 16.51% |
| 2011 Q4 | 634.76 Million BRL | -30.09% |
| 2011 Q1 | 845.24 Million BRL | -7.03% |
| 2011 FY | 3.32 Billion BRL | 5.22% |
| 2011 Q2 | 936.61 Million BRL | 10.81% |
| 2011 Q3 | 908 Million BRL | -3.05% |
| 2010 FY | 3.15 Billion BRL | 56.01% |
| 2010 Q3 | 835.87 Million BRL | 10.28% |
| 2010 Q2 | 757.94 Million BRL | 17.02% |
| 2010 Q4 | 909.12 Million BRL | 8.76% |
| 2010 Q1 | 647.68 Million BRL | -9.97% |
| 2009 Q2 | 423.07 Million BRL | 13.09% |
| 2009 Q1 | 374.09 Million BRL | 0.0% |
| 2009 FY | 2.02 Billion BRL | 51.93% |
| 2009 Q4 | 719.43 Million BRL | 44.45% |
| 2009 Q3 | 498.03 Million BRL | 17.72% |
| 2008 FY | 1.33 Billion BRL | 25.58% |
| 2007 FY | 1.06 Billion BRL | 179.15% |
| 2006 FY | 380.26 Million BRL | 9.68% |
| 2005 FY | 346.7 Million BRL | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 1.37 Billion BRL | -476.604% |